Opportunity ID: 316477

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-289
Funding Opportunity Title: Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 29, 2019
Last Updated Date: May 29, 2019
Original Closing Date for Applications: Sep 07, 2022
Current Closing Date for Applications: Sep 07, 2022
Archive Date: Oct 13, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
For profit organizations other than small businesses
Public and State controlled institutions of higher education
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Private institutions of higher education
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
City or township governments
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The overall goal of this Funding Opportunity Announcement (FOA) is to identify, in animals, in vivo neurophysiological and behavioral measures for use as assays in the early screening phase of treatment development. The FOA will support efforts to optimize and evaluate measures of neurophysiological and behavioral processes that may serve as surrogate markers of neural processes of clinical interest based on available knowledge of the neurobiology of mental illnesses. The screening assays thus developed from this FOA are expected to build upon systems neurobiology and clinical neuroscience to enhance the scientific value of preclinical animal data contributing to a therapeutic development pipeline by assessing the impact of therapeutic targets and treatment candidates on neurobiological mechanisms of clinical relevance to mental illnesses.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-289.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 316477 Full Announcement-PAR-19-289 -> PAR-19-289-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00251441 Sep 05, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00259339 Sep 05, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269718 Oct 28, 2021 Sep 07, 2022 View

Package 1

Mandatory forms

316477 RR_SF424_2_0-2.0.pdf

316477 PHS398_CoverPageSupplement_4_0-4.0.pdf

316477 RR_OtherProjectInfo_1_4-1.4.pdf

316477 PerformanceSite_2_0-2.0.pdf

316477 RR_KeyPersonExpanded_2_0-2.0.pdf

316477 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

316477 RR_Budget_1_4-1.4.pdf

316477 RR_SubawardBudget30_1_4-1.4.pdf

316477 PHS398_ModularBudget_1_2-1.2.pdf

316477 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

316477 RR_SF424_2_0-2.0.pdf

316477 PHS398_CoverPageSupplement_5_0-5.0.pdf

316477 RR_OtherProjectInfo_1_4-1.4.pdf

316477 PerformanceSite_2_0-2.0.pdf

316477 RR_KeyPersonExpanded_2_0-2.0.pdf

316477 PHS398_ResearchPlan_4_0-4.0.pdf

316477 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

316477 RR_Budget_1_4-1.4.pdf

316477 RR_SubawardBudget30_1_4-1.4.pdf

316477 PHS398_ModularBudget_1_2-1.2.pdf

316477 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

316477 RR_SF424_5_0-5.0.pdf

316477 PHS398_CoverPageSupplement_5_0-5.0.pdf

316477 RR_OtherProjectInfo_1_4-1.4.pdf

316477 PerformanceSite_4_0-4.0.pdf

316477 RR_KeyPersonExpanded_4_0-4.0.pdf

316477 PHS398_ResearchPlan_4_0-4.0.pdf

316477 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

316477 RR_Budget_3_0-3.0.pdf

316477 RR_SubawardBudget30_3_0-3.0.pdf

316477 PHS398_ModularBudget_1_2-1.2.pdf

316477 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T17:15:57-05:00

Share This Post, Choose Your Platform!

About the Author: